Literature DB >> 6698343

[Acute hepatitis due to carbamazepine (Tegretol). Study of a case and review of the literature].

T Davion, J P Capron, M Andrejak, P Geoffroy, D Capron-Chivrac, C Quénum.   

Abstract

The case of a 28-year-old epileptic woman, treated for 3 months with carbamazepine and who developed jaundice, fever and exfoliative dermatitis is reported. Biological investigations showed an increase in the activity of serum transaminases and alkaline phosphatases as well as in the blood eosinophilic count. Liver biopsy revealed centrolobular necrosis and cholestasis with portal inflammatory infiltrate. Drug challenge was followed by the rapid recurrence of clinical and biological signs. The definitive outcome was favorable. The analysis of the 12 previously published cases, and particularly the frequency of granulomatous hepatitis, suggests an immunoallergic mechanism for the development of carbamazepine hepatitis.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6698343

Source DB:  PubMed          Journal:  Gastroenterol Clin Biol        ISSN: 0399-8320


  4 in total

1.  Vascular hepatotoxicity related to heroin addiction.

Authors:  M S de Araújo; F Gerard; P Chossegros; L C Porto; P Barlet; J A Grimaud
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

2.  Transient cholestatic hepatitis in a neonate associated with carbamazepine exposure during pregnancy and breast-feeding.

Authors:  B Frey; G Schubiger; J P Musy
Journal:  Eur J Pediatr       Date:  1990-12       Impact factor: 3.183

3.  Lack of hepatocyte involvement in the genesis of the sinusoidal dilatation related to heroin addiction: a morphometric study.

Authors:  M S Trigueiro de Araújo; F Gérard; P Chossegros; S Guerret; J A Grimaud
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

4.  Carbamazepine-induced acute cholangitis.

Authors:  D Larrey; A Hadengue; D Pessayre; L Choudat; C DeGott; J P Benhamou
Journal:  Dig Dis Sci       Date:  1987-05       Impact factor: 3.199

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.